This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.C Dye , Consensus Statement. Global burden of turberculosis: estimated incidence, prevalence and mortality by country. Journal of the American Medical Association 1999; 282: 677–686.
3.S Ehlers . Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis. Infection 2009; 37: 87–95.
4.AM Cooper , SA Khader . The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunology Reviews 2008; 226: 191–204.
5.R Hussain , Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development. Clinical Vaccine Immunology 2007; 14: 1578–1586.
6.A Demissie , The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infection & Immunity 2006; 74: 2817–2822.
7.E Torrado , AM Cooper . IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Reviews 2010; 21: 455–462.
8.A Tsegaye , Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clinical Immunology 2003; 109: 338–346.
9.GF Black , BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002; 359: 1393–1401.
10.MK Lalor , BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. Journal of Infectious Diseases 2011; 204: 1075–1085.
11.GA Rook , K Dheda , A Zumla . Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Tuberculosis (Edinburgh) 2006; 86: 152–162.
12.H Esmail , CE Barry 3rd, RJ Wilkinson . Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discovery Today 2012; 17: 514–521.
13.GA Rook , K Dheda , A Zumla . Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine 2005; 23: 2115–2120.
14.S Perry , R Hussain , J Parsonnet . The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunology 2011; 4: 246–251.
15.S Perry , C de Martel , J Parsonnet . Helicobacter pylori. In: PS Brachman , EA Brutyn , eds. Bacterial Infections of Humans, 4th edn.New York: Springer, 2009.
16.MM D'Elios , Helicobacter pylori, T cells and cytokines: the ‘dangerous liaisons’. FEMS Immunology & Medical Microbiology 2005; 44: 113–119.
17.S Perry , Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 2010; 5: 1–9.e8804.
18.PJ Hotez , Helminth infections: the great neglected tropical diseases. Journal of Clinical Investigation 2008; 118: 1311–1321.
19.RM Maizels , M Yazdanbakhsh . Immune regulation by helminth parasites: cellular and molecular mechanisms. Nature Reviews Immunology 2003; 3: 733–744.
20.PJ Cooper , Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infection & Immunity 2001; 69: 1574–1580.
21.A Kassu , Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clinical & Experimental Immunology 2003; 132: 113–119.
22.D Elias , Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 2008; 26: 3897–3902.
23.JG Fox , Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nature Medicine 2000; 6: 536–542.
25.A Lundgren , Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infection & Immunity 2003; 71: 1755–1762.
26.JE Allen , RM Maizels . Diversity and dialogue in immunity to helminths. Nature Reviews Immunology 2011; 11: 375–388.
27.RM Maizels . Infections and allergy – helminths, hygiene and host immune regulation. Current Opinions in Immunology 2005; 17: 656–661.
28.MJ Blaser , Y Chen , J Reibman . Does Helicobacter pylori protect against asthma and allergy? Gut 2008; 57: 561–567.
29.M Wills-Karp , J Santeliz , CL Karp . The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Reviews Immunology 2001; 1: 69–75.
30.P Ricks , Estimating the burden of tuberculosis among foreign born persons acquired prior to entering the U.S., 2005–2009. PLoS One 2011; 6: 1–6.
31.S Perry , Reproducibility of QuantiFERON-TB gold in-tube assay. Clinical Vaccine Immunology 2008; 15: 425–432.
33.C de Martel , Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. Journal of Infectious Diseases 2005; 191: 761–767.
35.A Agresti . An Introduction to Categorical Data Analysis, 2nd edn.Hoboken, New Jersey: John Wiley & Sons, 2007.
36.D Elias , H Akuffo , S Britton . Helminths could influence the outcome of vaccines against TB in the tropics. Parasite Immunology 2006; 28: 507–513.
37.MK Lalor , Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. Journal of Infectious Diseases 2009; 199: 795–800.
38.PL Lin , JL Flynn . Understanding latent tuberculosis: a moving target. Journal of Immunology 2010; 185: 15–22.
42.V Herrera , Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clinical Infectious Diseases 2011; 52: 1031–1037.
43.N Cerf-Bensussan , V Gaboriau-Routhiau . The immune system and the gut microbiota: friends or foes? Nature Reviews Immunology 2010; 10: 735–744.